Department of Intensive Care Medicine, Ningbo No.2 Hospital, Ningbo, 315000, Zhejiang, China.
Department of Emergency, Ningbo Yinzhou No.2 Hospital, Ningbo, 315000, Zhejiang, China.
Crit Care. 2023 May 26;27(1):203. doi: 10.1186/s13054-023-04480-z.
Since oxygen content and oxygen consumption typically remain unchanged within a short period, variation in central venous oxygen saturation (ΔScvO) during fluid challenge can theoretically track the changes in cardiac output (CO). We conducted this meta-analysis to systematically assess the diagnostic performance of ΔScvO during a fluid challenge for fluid responsiveness in mechanically ventilated patients receiving volume expansion.
Electronic databases were systematically searched to identify relevant studies published before October 24, 2022. As the cutoff value of ΔScvO was expected to vary across the included studies, we estimated the area under the hierarchical summary receiver operating characteristic curve (AUHSROC) as the primary measure of diagnostic accuracy. The optimal threshold of ΔScvO and the corresponding 95% confidential interval (CI) were also estimated.
This meta-analysis included 5 observational studies comprising 240 participants, of whom 133 (55%) were fluid responders. Overall, the ΔScvO during the fluid challenge exhibited excellent performance for defining fluid responsiveness in mechanically ventilated patients receiving volume expansion, with an AUHSROC of 0.86 (95% CI 0.83-0.89), a pooled sensitivity of 0.78 (95% CI 0.69-0.85), a pooled specificity of 0.84 (95% CI 0.72-0.91), and a pooled diagnostic odds ratio of 17.7 (95% CI 5.9-53.2). The distribution of the cutoff values was nearly conically symmetrical and concentered between 3 and 5%; the mean and median cutoff values were 4% (95% CI 3-5%) and 4% (95% CI not estimable), respectively.
In mechanically ventilated patients receiving volume expansion, the ΔScvO2 during the fluid challenge is a reliable indicator of fluid responsiveness. Clinical trial registration PROSPERO, https://www.crd.york.ac.uk/prospero/ , registry number: CRD42022370192.
由于氧含量和氧消耗在短时间内通常保持不变,因此在液体冲击期间中心静脉血氧饱和度(ΔScvO)的变化理论上可以跟踪心输出量(CO)的变化。我们进行了这项荟萃分析,以系统评估在接受容量扩张的机械通气患者进行液体冲击期间ΔScvO 对液体反应性的诊断性能。
系统搜索电子数据库以确定截至 2022 年 10 月 24 日之前发表的相关研究。由于预计 ΔScvO 的截止值在纳入的研究中会有所不同,因此我们估计分层综合受试者工作特征曲线下面积(AUHSROC)作为诊断准确性的主要衡量标准。还估计了 ΔScvO 的最佳阈值及其相应的 95%置信区间(CI)。
这项荟萃分析包括 5 项观察性研究,共纳入 240 名参与者,其中 133 名(55%)为液体反应者。总体而言,液体冲击期间的 ΔScvO 对接受容量扩张的机械通气患者的液体反应性具有出色的表现,AUHSROC 为 0.86(95%CI 0.83-0.89), pooled 敏感性为 0.78(95%CI 0.69-0.85), pooled 特异性为 0.84(95%CI 0.72-0.91), pooled 诊断比值比为 17.7(95%CI 5.9-53.2)。截止值的分布几乎呈圆锥形对称,集中在 3%至 5%之间;平均和中位数截止值分别为 4%(95%CI 3%-5%)和 4%(95%CI 无法估计)。
在接受容量扩张的机械通气患者中,液体冲击期间的 ΔScvO2 是液体反应性的可靠指标。临床试验注册 PROSPERO,https://www.crd.york.ac.uk/prospero/ ,注册号:CRD42022370192。